Ji, L.; Zhan, Y.; Wu, B.; Chen, P.; Cheng, L.; Ke, Y.; Zhuang, X.; Hua, F.; Sun, L.; Chen, H.;
et al. TCR CDR3 Sequencing as a Clue to Elucidate the Landscape of Dysimmunity in Patients with Primary Immune Thrombocytopenia. J. Clin. Med. 2022, 11, 5665.
https://doi.org/10.3390/jcm11195665
AMA Style
Ji L, Zhan Y, Wu B, Chen P, Cheng L, Ke Y, Zhuang X, Hua F, Sun L, Chen H,
et al. TCR CDR3 Sequencing as a Clue to Elucidate the Landscape of Dysimmunity in Patients with Primary Immune Thrombocytopenia. Journal of Clinical Medicine. 2022; 11(19):5665.
https://doi.org/10.3390/jcm11195665
Chicago/Turabian Style
Ji, Lili, Yanxia Zhan, Boting Wu, Pu Chen, Luya Cheng, Yang Ke, Xibing Zhuang, Fanli Hua, Lihua Sun, Hao Chen,
and et al. 2022. "TCR CDR3 Sequencing as a Clue to Elucidate the Landscape of Dysimmunity in Patients with Primary Immune Thrombocytopenia" Journal of Clinical Medicine 11, no. 19: 5665.
https://doi.org/10.3390/jcm11195665
APA Style
Ji, L., Zhan, Y., Wu, B., Chen, P., Cheng, L., Ke, Y., Zhuang, X., Hua, F., Sun, L., Chen, H., Li, F., & Cheng, Y.
(2022). TCR CDR3 Sequencing as a Clue to Elucidate the Landscape of Dysimmunity in Patients with Primary Immune Thrombocytopenia. Journal of Clinical Medicine, 11(19), 5665.
https://doi.org/10.3390/jcm11195665
